(Q38215937)

31 August 2017

Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care (English)

1 reference

acute respiratory distress syndrome

31 August 2017

0 references

1 reference

3

Lorraine B Ware

1 reference

31 August 2017

James M Walter

1

1 reference

PubMed ID

24875533

31 August 2017

Jennifer Wilson

series ordinal

2

1 reference

31 August 2017

30 May 2014

1 reference

Expert Review of Respiratory Medicine

31 August 2017

1 reference

31 August 2017

8

1 reference

31 August 2017

5

1 reference

31 August 2017

573-586

1 reference

Acute respiratory distress in adults

31 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Epidemiology and outcome of acute respiratory failure in intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Mortality rates for patients with acute lung injury/ARDS have decreased over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Functional disability 5 years after acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

The changing pattern of acute respiratory distress syndrome over time: a comparison of two periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Targeting targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

The value of edema fluid protein measurement in patients with pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Regulation and repair of the alveolar-capillary barrier in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Angiopoietin signaling in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

A role for vascular endothelial growth factor in acute and resolving lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Decreased VEGF concentration in lung tissue and vascular injury during ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Function of von Willebrand factor in haemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Selectins: lectins that initiate cell adhesion under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Soluble form of P-selectin in plasma is elevated in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Pulmonary surfactant: an immunological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Prognostic value of surfactant proteins A and D in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Cellular signalling of the receptor for advanced glycation end products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Infections and the inflammatory response in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

HMGB1 is a therapeutic target for sterile inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma protein C levels in patients with acute lung injury: prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Protein C and thrombomodulin in human acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

SuPAR and PAI-1 in critically ill, mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Discovery of the gene signature for acute lung injury in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Genomics and proteomics of lung disease: conference summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Role of nonbronchoscopic lavage for investigating alveolar inflammation and permeability in acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

The association between BMI and plasma cytokine levels in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Plasma biomarkers in acute respiratory distress syndrome: a work in progress*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.924073

10.1586/17476348.2014.924073

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24875533